Y-Biologics Inc

[On Demand]
Search General Info
Search Education
Search Partnering Companies
Y-Biologics Inc. is a biotech company focused on the discovery and development of antibody therapeutics with various modalities including monoclonal antibody, bispecific antibody, and antibody-drug conjugates (ADC) in the field of immuno-oncology and autoimmune disease. Founded in 2007, we have dedicated ourselves on building and validating our two main platform technologies, a naïve cDNA human antibody library (Ymax®-ABL) and a novel format of T cell bispecific antibody (ALiCE).
Since our platforms consist of the original technologies for antibody discovery, we have a various business model which allows to conduct joint research and co-development. The recent global achievements of Y-Biologics also started with these powerful proprietary platforms and it is a promising company that can continue to grow and develop in the future.
Company Type:
Privately Funded Company
Company HQ State:
Not Provided
Company HQ Country:
Korea - South Korea
Year Founded:
2007
Main Therapeutic Focus:
Lead Product in Development:
YBL-006(Anti PD-1 monoclonal antibody)
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
Manager
Y-Biologics Inc.